M. E. Aguero-rosenfeld, J. Nowakowski, S. Bittker, D. Cooper, R. B. Nadelman et al., Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans, J. Clin. Microbiol, vol.34, pp.1-9, 1996.

M. E. Aguero-rosenfeld, J. Nowakowski, D. F. Mckenna, C. A. Carbonaro, and G. P. Wormser, Serodiagnosis in early Lyme disease, J. Clin. Microbiol, vol.31, pp.3090-3095, 1993.

E. Akin, G. L. Mchugh, R. A. Flavell, E. Fikrig, and A. C. Steere, The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis, Infect. Immun, vol.67, pp.173-181, 1999.

J. Aucott, C. Morrison, B. Munoz, P. C. Rowe, A. Schwarzwalder et al., Diagnostic challenges of early Lyme disease: lessons from a community case series, BMC Infect. Dis, vol.9, p.79, 2009.

J. N. Aucott, M. J. Soloski, A. W. Rebman, L. A. Crowder, L. J. Lahey et al., CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study, Clin. Vaccine Immunol, vol.23, pp.757-766, 2016.

A. G. Barbour, M. Adeolu, R. S. Gupta, and . Margos, Division of the genus Borrelia into two genera (corresponding to Lyme disease and relapsing fever groups) reflects their genetic and phenotypic distinctiveness and will lead to a better understanding of these two groups of microbes, Int. J. Syst. Evol. Microbiol, vol.67, pp.2058-2067, 2016.

T. G. Berger, C. Schoerner, H. Schell, M. Simon, G. Schuler et al., Two unusual cases of diffuse acrodermatitis chronica atrophicans seronegative for Lyme borreliosis, Eur. J. Clin. Microbiol. Infect. Dis, vol.22, pp.392-395, 2003.

F. Blanc, B. Jaulhac, M. Fleury, J. De-seze, S. J. De-martino et al., Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients, Neurology, vol.69, pp.953-958, 2007.

J. A. Branda, M. E. Aguero-rosenfeld, M. J. Ferraro, B. J. Johnson, G. P. Wormser et al., 2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test, Clin. Infect. Dis, vol.50, pp.20-26, 2010.

J. A. Branda, K. Linskey, Y. A. Kim, A. C. Steere, and M. J. Ferraro, Twotiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay, Clin. Infect. Dis, vol.53, pp.541-547, 2011.

J. A. Branda, F. Strle, K. Strle, N. Sikand, M. J. Ferraro et al., Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe, Clin. Infect. Dis, vol.57, pp.333-340, 2013.

J. A. Branda, K. Strle, L. E. Nigrovic, P. M. Lantos, T. J. Lepore et al., Evaluation of modified 2-tiered serodiagnostic testing algorithms for early Lyme disease, Clin. Infect. Dis, vol.64, pp.1074-1080, 2017.

P. Breitbart, S. Meister, T. Meyer, and B. C. Gärtner, Incidence and prevalence of Borrelia burgdorferi antibodies in male professional football players, Clin. J. Sport Med, 2019.

W. Burgdorfer, A. G. Barbour, S. F. Hayes, J. L. Benach, E. Grunwaldt et al., Lyme disease-a tick-borne spirochetosis?, Science, vol.216, pp.1317-1319, 1982.

S. E. Carrasco, B. Troxell, Y. Yang, S. L. Brandt, H. Li et al., Outer surface protein OspC is an antiphagocytic factor that protects Borrelia burgdorferi from phagocytosis by macrophages, Infect. Immun, vol.83, pp.4848-4860, 2015.

, Recommendations for test performance and interpretation from the Second National Conference on serologic diagnosis of Lyme disease, Centers for Disease Control and Prevention, vol.44, pp.590-591, 1995.

C. S. Cheung, K. W. Anderson, K. Y. Benitez, M. J. Soloski, J. N. Aucott et al., Quantification of Borrelia burgdorferi membrane proteins in human serum: a new concept for detection of bacterial infection, Anal. Chem, vol.87, pp.11383-11388, 2015.

J. T. Crowley, E. E. Drouin, A. Pianta, K. Strle, Q. Wang et al., A highly expressed human protein, apolipoprotein B-100, serves as an autoantigen in a subgroup of patients with Lyme disease, J. Infect. Dis, vol.212, pp.1841-1850, 2015.

S. J. Cutler, E. Ruzic-sabljic, and A. Potkonjak, Emerging borreliae -expanding beyond Lyme borreliosis, Mol. Cell. Probes, vol.31, pp.22-27, 2017.

R. B. Dessau, J. K. Møller, B. Kolmos, and A. J. Henningsson, Multiplex assay (Mikrogen recomBead) for detection of serum IgG and IgM antibodies to 13 recombinant antigens of Borrelia burgdorferi sensu lato in patients with neuroborreliosis: the more the better?, J. Med. Microbiol, vol.64, pp.224-231, 2015.

R. B. Dessau, A. P. Van-dam, V. Fingerle, J. Gray, J. W. Hovius et al., To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis, Clin. Microbiol. Infect, vol.24, pp.118-124, 2018.

F. Dressler, J. A. Whalen, B. N. Reinhardt, and A. C. Steere, Western blotting in the serodiagnosis of Lyme disease, J. Infect. Dis, vol.167, pp.392-400, 1993.

H. Eiffert, A. Karsten, R. Thomssen, C. , and H. J. , Characterization of Borrelia burgdorferi strains in Lyme arthritis, Scand. J. Infect. Dis, vol.30, pp.265-268, 1998.

C. Eldin, B. Jaulhac, O. Mediannikov, J. Arzouni, and D. Raoult, Values of diagnostic tests for the various species of spirochetes, Med. Mal. Infect, vol.49, pp.102-111, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02262539

C. Eldin, A. Raffetin, K. Bouiller, Y. Hansmann, F. Roblot et al., Review of European and American guidelines for the diagnosis of Lyme borreliosis, Med. Mal. Infect, vol.49, pp.121-132, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02559190

S. M. Engstrom, E. Shoop, J. , and R. C. , Immunoblot interpretation criteria for serodiagnosis of early Lyme disease, J. Clin. Microbiol, vol.33, pp.419-427, 1995.

H. Fahrer, M. J. Sauvain, E. Zhioua, C. Van-hoecke, and L. E. Gern, Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals?, Eur. J. Epidemiol, vol.14, pp.117-123, 1998.

H. M. Feder, M. A. Gerber, S. W. Luger, and R. W. Ryan, Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease, Clin. Infect. Dis, vol.15, pp.788-793, 1992.

E. Fikrig, S. W. Barthold, W. Sun, W. Feng, S. R. Telford et al., Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity, Immunity, vol.6, pp.80341-80347, 1997.

A. Fotso-fotso and M. Drancourt, Laboratory diagnosis of tick-borne African relapsing fevers: latest developments. Front, Public Health, vol.3, p.254, 2015.

A. Fotso-fotso, O. Mediannikov, C. Nappez, S. Azza, D. Raoult et al., Monoclonal antibodies for the diagnosis of Borrelia crocidurae, Am. J. Trop. Med. Hyg, vol.94, pp.61-67, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01459927

B. L. Garcia, H. Zhi, B. Wager, M. Höök, and J. T. Skare, Borrelia burgdorferi BBK32 inhibits the classical pathway by blocking activation of the C1 complement complex, PLoS Pathog, vol.12, p.1005404, 2016.

A. Grillon, M. Scherlinger, P. Boyer, S. De-martino, A. Perdriger et al., Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis, Semin. Arthritis Rheum, vol.48, pp.1105-1112, 2019.

J. J. Halperin, P. Baker, and G. P. Wormser, Common misconceptions about Lyme disease, Am. J. Med, vol.126, pp.1-7, 2013.

K. Hansen and A. M. Lebech, Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferispecific immunoglobulin G, A, and M, Ann. Neurol, vol.30, pp.197-205, 1991.

K. Hansen and A. M. Lebech, The clinical and epidemiological profile of Lyme neuroborreliosis in Denmar 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production, Brain, vol.115, issue.2, pp.399-423, 1992.

K. Hansen, K. Pii, and A. M. Lebech, Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella, J. Clin. Microbiol, vol.29, pp.166-173, 1991.

T. Harrer, W. Geissdörfer, C. Schoerner, E. Lang, and G. Helm, , 2007.

, Seronegative Lyme neuroborreliosis in a patient on treatment for chronic lymphatic leukemia, Infection, vol.35, pp.110-113

U. Hauser, G. Lehnert, R. Lobentanzer, and B. Wilske, Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato, J. Clin. Microbiol, vol.35, pp.1433-1444, 1997.

U. Hauser, G. Lehnert, and B. Wilske, Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe, Clin. Diagn. Lab. Immunol, vol.5, pp.456-462, 1998.

U. Hauser, G. Lehnert, and B. Wilske, Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe, J. Clin. Microbiol, vol.37, pp.2241-2247, 1999.

H. Hegen, D. Milosavljevic, C. Schnabl, A. Manowiecka, J. Walde et al., Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis, Clin. Chem. Lab. Med, vol.56, pp.1383-1391, 2018.

A. Holl-wieden, S. Suerbaum, and H. J. Girschick, Seronegative Lyme arthritis, Rheumatol. Int, vol.27, pp.1091-1093, 2007.

K. Hunfeld, G. Stanek, E. Straube, H. Hagedorn, C. Schörner et al., Quality of Lyme disease serology. Lessons from the German proficiency testing program 1999-2001. A preliminary report, Wien. Klin. Wochenschr, vol.114, pp.591-600, 2002.

K. P. Hunfeld and P. Kraiczy, When is the best time to order a Western blot and how should it be interpreted?, Curr. Probl. Dermatol, vol.37, pp.167-177, 2009.

E. Jacek, B. A. Fallon, A. Chandra, M. K. Crow, G. P. Wormser et al., Increased IFN? activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits, J. Neuroimmunol, vol.255, pp.85-91, 2013.

S. Jahfari, D. S. Sarksyan, N. M. Kolyasnikova, J. W. Hovius, H. Sprong et al., Evaluation of a serological test for the diagnosis of Borrelia miyamotoi disease in Europe, J. Microbiol. Methods, vol.136, pp.11-16, 2017.

B. Jaulhac, A. Saunier, E. Caumes, K. Bouiller, J. F. Gehanno et al., Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II), Med. Mal. Infect, vol.49, pp.335-346, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02179385

B. J. Johnson, K. E. Robbins, R. E. Bailey, B. L. Cao, S. L. Sviat et al., Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting, J. Infect. Dis, vol.174, pp.346-353, 1996.

A. T. Kaell, P. R. Redecha, K. B. Elkon, M. G. Golightly, P. E. Schulman et al., Occurrence of antibodies to Borrelia burgdorferi in patients with nonspirochetal subacute bacterial endocarditis, Ann. Intern. Med, vol.119, pp.1079-1083, 1993.

R. A. Kalish, G. Mchugh, J. Granquist, B. Shea, R. Ruthazer et al., Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease, Clin. Infect. Dis, vol.33, pp.780-785, 2001.

B. Keymeulen, G. Somers, A. Naessens, and L. A. Verbruggen, False positive ELISA serologic test for lyme borreliosis in patients with connective tissue diseases, Clin. Rheumatol, vol.12, pp.526-528, 1993.

J. Koetsveld, N. M. Kolyasnikova, A. Wagemakers, O. A. Stukolova, D. Hoornstra et al., Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins, Clin. Microbiol. Infect, vol.24, 2018.

P. J. Krause, M. Carroll, N. Fedorova, J. Brancato, C. Dumouchel et al., Human Borrelia miyamotoi infection in California: serodiagnosis is complicated by multiple endemic Borrelia species, PLoS ONE, vol.13, p.191725, 2018.

P. J. Krause, S. Narasimhan, G. P. Wormser, A. G. Barbour, A. E. Platonov et al., Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the Northeastern United States, Emerg. Infect. Dis, vol.20, pp.1183-1190, 2014.

P. J. Krause, S. Narasimhan, G. P. Wormser, L. Rollend, E. Fikrig et al., Human Borrelia miyamotoi infection in the United States, N. Engl. J. Med, vol.368, pp.291-293, 2013.

M. B. Lawrenz, J. M. Hardham, R. T. Owens, J. Nowakowski, A. C. Steere et al., Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi, J. Clin. Microbiol, vol.37, pp.3997-4004, 1999.

T. B. Ledue, M. F. Collins, J. Young, and M. E. Schriefer, Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease, Clin. Vaccine Immunol, vol.15, pp.1796-1804, 2008.

M. M. Leeflang, C. W. Ang, J. Berkhout, H. A. Bijlmer, W. Van-bortel et al., The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis, BMC Infect. Dis, vol.16, p.140, 2016.

C. Lenormand, B. Jaulhac, S. Debarbieux, N. Dupin, F. Granel-brocard et al., Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): A prospective study of 20 culture-and/or polymerase chain reaction (PCR)-documented cases, J. Am. Acad. Dermatol, vol.74, pp.685-692, 2016.

F. T. Liang, A. C. Steere, A. R. Marques, B. J. Johnson, J. N. Miller et al., Sensitive and specific serodiagnosis of Lyme disease by enzymelinked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE, J. Clin. Microbiol, vol.37, pp.3990-3996, 1999.

S. C. Lipsett, J. A. Branda, and L. E. Nigrovic, Evaluation of the modified two-tiered testing method for diagnosis of Lyme disease in children, J. Clin. Microbiol, vol.57, pp.547-566, 2019.

L. A. Magnarelli, J. F. Anderson, J. , and R. C. , Cross-reactivity in serological tests for Lyme disease and other spirochetal infections, J. Infect. Dis, vol.156, pp.183-188, 1987.

L. A. Magnarelli, J. N. Miller, J. F. Anderson, and G. R. Riviere, Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease, J. Clin. Microbiol, vol.28, pp.1276-1279, 1990.

R. Magni, B. H. Espina, K. Shah, B. Lepene, C. Mayuga et al., Application of nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis, J. Transl. Med, vol.13, p.346, 2015.

A. Marangoni, A. Moroni, S. Accardo, and R. Cevenini, Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis, Eur. J. Clin. Microbiol. Infect. Dis, vol.27, pp.349-354, 2008.

G. Margos, D. Marosevic, S. Cutler, M. Derdakova, M. Diuk-wasser et al., There is inadequate evidence to support the division of the genus Borrelia, Int. J. Syst. Evol. Microbiol, vol.67, pp.1081-1084, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02496354

M. Markowicz, A. Schötta, M. Kundi, ?. Bogovi, P. Ogrinc et al., CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA, Ticks Tick Borne Dis, vol.9, pp.1137-1142, 2018.

A. Marques, M. R. Brown, and T. A. Fleisher, Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls, Clin. Vaccine Immunol, vol.16, pp.1249-1250, 2009.

A. Marques, S. R. Telford, S. Turk, E. Chung, C. Williams et al., Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study, Clin. Infect. Dis, vol.58, pp.937-945, 2014.

M. J. Mathiesen, M. Christiansen, K. Hansen, A. Holm, E. Asbrink et al., Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis, J. Clin. Microbiol, vol.36, pp.3474-3479, 1998.

P. Mead, Updated CDC recommendation for serologic diagnosis of Lyme disease, MMWR Morb. Mortal. Wkly. Rep, vol.68, p.703, 2019.

C. R. Molins, M. J. Delorey, A. Replogle, C. Sexton, and M. E. Schriefer, Evaluation of bioMérieux's dissociated vidas Lyme IgM II and IgG II as a first-tier diagnostic assay for Lyme disease, J. Clin. Microbiol, vol.55, pp.1698-1706, 2017.

C. R. Molins, M. J. Delorey, C. Sexton, and M. E. Schriefer, Lyme borreliosis serology: performance of several commonly used laboratory diagnostic tests and a large resource panel of well-characterized patient samples, J. Clin. Microbiol, vol.54, pp.2726-2734, 2016.

R. B. Nadelman, Á. Hanincov, K. Mukherjee, P. Liveris, D. Nowakowski et al., Differentiation of reinfection from relapse in recurrent Lyme disease, N. Engl. J. Med, vol.367, pp.1883-1890, 2012.

J. Nowakowski, I. Schwartz, D. Liveris, G. Wang, M. E. Aguero-rosenfeld et al., Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques, Clin. Infect. Dis, vol.33, pp.2023-2027, 2001.

K. Ogrinc, S. Lotri?-furlan, V. Maraspin, L. Lusa, T. Cerar et al., Suspected early Lyme neuroborreliosis in patients with erythema migrans, Clin. Infect. Dis, vol.57, pp.501-509, 2013.

K. Ogrinc, L. Lusa, S. Lotri?-furlan, ?. Bogovi, P. Stupica et al., Course and outcome of early European Lyme neuroborreliosis (Bannwarth Syndrome): clinical and laboratory findings, Clin. Infect. Dis, vol.63, pp.346-353, 2016.

J. Panelius, P. Lahdenne, H. Saxén, S. Carlsson, T. Heikkilä et al., Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide, J. Neurol, vol.250, pp.1318-1327, 2003.

H. W. Pfister, U. Neubert, B. Wilske, V. Preac-mursic, K. M. Einhäupl et al., Reinfection with Borrelia burgdorferi, Lancet Lond. Engl, vol.2, issue.86, pp.90640-90649, 1986.

K. Pierer, D. Stünzner, M. Feichtinger, C. N. Homann, G. Kleinert et al., Is IgM of diagnostic value in case of delayed intrathecal production of IgG antibodies?, Wien. Klin. Wochenschr, vol.111, pp.957-960, 1999.

A. Pietikäinen, J. Oksi, and J. Hytönen, Point-of-care testing for CXCL13 in Lyme neuroborreliosis, Diagn. Microbiol. Infect. Dis, vol.91, pp.226-228, 2018.

A. E. Platonov, L. S. Karan, N. M. Kolyasnikova, N. A. Makhneva, M. G. Toporkova et al., Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg. Infect. Dis, vol.17, pp.1816-1823, 2011.

R. B. Porwancher, C. G. Hagerty, J. Fan, L. Landsberg, B. J. Johnson et al., Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics, Clin. Vaccine Immunol, vol.18, pp.851-859, 2011.

A. Raffetin, A. Saunier, K. Bouiller, P. Caraux-paz, C. Eldin et al., Unconventional diagnostic tests for Lyme borreliosis: a systematic review, Clin. Microbiol. Infect, vol.26, pp.51-59, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02559165

D. Raoult, K. E. Hechemy, and G. Baranton, Cross-reaction with Borrelia burgdorferi antigen of sera from patients with human immunodeficiency virus infection, syphilis, and leptospirosis, J. Clin. Microbiol, vol.27, pp.2152-2155, 1989.

H. Reiber and J. B. Peter, Cerebrospinal fluid analysis: diseaserelated data patterns and evaluation programs, J. Neurol. Sci, vol.184, pp.101-122, 2001.

N. Reslova, V. Michna, M. Kasny, P. Mikel, and P. Kralik, xMAP technology: applications in detection of pathogens, Front. Microbiol, vol.8, p.55, 2017.

E. Rigaud, B. Jaulhac, N. Garcia-bonnet, K. Hunfeld, F. Féménia et al., Seroprevalence of seven pathogens transmitted by the Ixodes ricinus tick in forestry workers in France, Clin. Microbiol. Infect, vol.22, pp.1-9, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01602513

T. A. Rupprecht, K. M. Manz, V. Fingerle, C. Lechner, M. Klein et al., Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis, Clin. Microbiol. Infect, vol.24, pp.1234-1240, 2018.

T. A. Rupprecht, H. W. Pfister, B. Angele, S. Kastenbauer, B. Wilske et al., The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis, Neurology, vol.65, pp.448-450, 2005.

U. Schulte-spechtel, G. Lehnert, G. Liegl, V. Fingerle, C. Heimerl et al., Significant improvement of the recombinant Borreliaspecific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis, J. Clin. Microbiol, vol.41, pp.1299-1303, 2003.

T. G. Schwan, M. E. Schrumpf, B. J. Hinnebusch, D. E. Anderson, and M. E. Konkel, GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis, J. Clin. Microbiol, vol.34, pp.2483-2492, 1996.

M. Senel, T. A. Rupprecht, H. Tumani, H. W. Pfister, A. C. Ludolph et al., The chemokine CXCL13 in acute neuroborreliosis, J. Neurol. Neurosurg. Psychiatry, vol.81, pp.929-933, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00557426

V. Seriburi, N. Ndukwe, Z. Chang, M. E. Cox, and G. P. Wormser, High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice, Clin. Microbiol. Infect, vol.18, pp.1236-1240, 2012.

G. Stanek, V. Fingerle, K. Hunfeld, B. Jaulhac, R. Kaiser et al., Lyme borreliosis: clinical case definitions for diagnosis and management in Europe, Clin. Microbiol. Infect, vol.17, pp.69-79, 2011.

F. Strle and G. Stanek, Clinical manifestations and diagnosis of lyme borreliosis, Curr. Probl. Dermatol, vol.37, pp.51-110, 2009.

K. Strle, K. B. Sulka, A. Pianta, J. T. Crowley, S. L. Arvikar et al., T-Helper 17 cell cytokine responses in Lyme disease correlate with Borrelia burgdorferi antibodies during early infection and with autoantibodies late in the illness in patients with antibiotic-refractory Lyme arthritis, Clin. Infect. Dis, vol.64, pp.930-938, 2017.

E. Talagrand-reboul, P. H. Boyer, S. Bergström, L. Vial, and N. Boulanger, Relapsing fevers: neglected tick-borne diseases, Front. Cell. Infect. Microbiol, vol.8, p.98, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02621125

E. S. Theel, M. Sorenson, and D. Granger, Evaluation of a novel microarray immunoblot assay for detection of IgM-and IgG-class antibodies to Borrelia burgdorferi, J. Clin. Microbiol, vol.56, pp.992-1010, 2018.

I. Tjernberg, M. Johansson, and A. J. Henningsson, Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis -a pilot study, Clin. Chem. Lab. Med, vol.57, 2008.

H. Tumani, G. Nölker, and H. Reiber, Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis, Neurology, vol.45, pp.1663-1670, 1995.

T. Tuuminen, K. Hedman, M. Söderlund-venermo, and I. Seppälä, Acute parvovirus B19 infection causes nonspecificity frequently in Borrelia and less often in Salmonella and Campylobacter serology, posing a problem in diagnosis of infectious arthropathy, Clin. Vaccine Immunol, vol.18, pp.167-172, 2011.

L. A. Waddell, J. Greig, M. Mascarenhas, S. Harding, R. Lindsay et al., The accuracy of diagnostic tests for Lyme disease in humans, a systematic review and meta-analysis of North American research, PLoS ONE, vol.11, 2016.

B. J. Webber, R. P. Burganowski, L. Colton, J. D. Escobar, S. R. Pathak et al., Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study, Clin. Microbiol. Infect, vol.25, pp.1233-1238, 2019.

B. Wilske, Microbiological diagnosis in Lyme borreliosis, Int. J. Med. Microbiol, vol.291, pp.114-119, 2002.

B. Wilske, G. Schierz, V. Preac-mursic, K. Busch, R. Kühbeck et al., Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome), J. Infect. Dis, vol.153, pp.304-314, 1986.

S. J. Wong, G. S. Brady, and J. S. Dumler, Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State, J. Clin. Microbiol, vol.35, pp.2198-2205, 1997.

G. P. Wormser, H. W. Horowitz, J. S. Dumler, I. Schwartz, and M. Aguero-rosenfeld, False-positive Lyme disease serology in human granulocytic ehrlichiosis, Lancet Lond. Engl, vol.347, pp.981-982, 1996.

J. Yang, X. Han, A. Liu, F. Bao, Y. Peng et al., Chemokine CXC ligand 13 in cerebrospinal fluid can be used as an early diagnostic biomarker for lyme neuroborreliosis: a meta-analysis, J. Interferon Cytokine Res, vol.37, pp.433-439, 2017.